AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management
AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management
Active, not recruiting · NCT06376851 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not stated | 2026-09-15 | NCT06376851 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| HeartFlow, Inc. | 10 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Moses Cone Memorial Hospital | Greensboro | United States | 2 |